A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Katiyar SK. Emerging phytochemicals for the prevention and treatment of head and neck cancer. Molecules. 2016 Nov 24;21(12):1610.
   PubMed Web of Science ®Google Scholar
• Fleming JC, Woo J, Moutasim K, et al. HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma. Br J Cancer. 2019 Feb;120(3):356–367.
   PubMed Web of Science ®Google Scholar
• Nelson HH, Pawlita M, Michaud DS, et al. Immune response to HPV16 E6 and E7 proteins and patient outcomes in head and neck cancer. JAMA Oncol. 2016;3(2):178–185.
   Web of Science ®Google Scholar
• Posner M, Vermorken JB. Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer. Semin Oncol. 2008 Jun;35(3):221–228.
   PubMed Web of Science ®Google Scholar
• Romano E, Romero P. The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors. J Immunother Cancer. 2015;3(1):15.
   PubMed Web of Science ®Google Scholar
• Wang SM, Jiang B, Deng Y, et al. Clinical significance of MLH1/MSH2 for stage II/III sporadic colorectal cancer. World J Gastrointest Oncol. 2019 Nov 15;11(11):1065–1080.
   PubMed Web of Science ®Google Scholar
• Schepisi G, Brighi N, Cursano MC, et al. Inflammatory biomarkers as predictors of response to immunotherapy in urological tumors. J Oncol. 2019 Sep 19;2019:7317964.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhou S, Du Y, et al. Efficacy and safety of programmed death 1 inhibitors in patients with advanced non-small cell lung cancer: a meta-analysis. Cancer Manag Res. 2019 May 21;11:4619–4630.
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018 Jan 25;172(3):393–407.
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long noncoding RNAs: at the intersection of cancer and chromatin biology. Cold Spring Harb Perspect Med. 2017 Jul 5;7(7):a026492.
   PubMed Web of Science ®Google Scholar
• Mao R, Chen Y, Xiong L, et al. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Aging (Albany NY). 2020 Oct 22;12(20):20778–20800.
   PubMedGoogle Scholar
• Bao S, Zhao H, Yuan J, et al. Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer. Brief Bioinform. 2020 Sep 25;21(5):1742–1755.
   PubMed Web of Science ®Google Scholar
• Martinez LM, Robila V, Clark NM, et al. Regulatory T cells control the switch from in situ to invasive breast cancer. Front Immunol. 2019;10:1942.
   PubMed Web of Science ®Google Scholar
• Peng D, Wang L, Li H, et al. An immune infiltration signature to predict the overall survival of patients with colon cancer. IUBMB Life. 2019 Nov;71(11):1760–1770.
   PubMed Web of Science ®Google Scholar
• Li AL, Zhu YM, Gao LQ, et al. Exploration of the immune-related signatures and immune infiltration analysis in Melanoma. Anal Cell Pathol (Amst). 2021 Jan 16;2021:4743971.
   PubMedGoogle Scholar
• Atianand MK, Caffrey DR, Fitzgerald KA. Immunobiology of long noncoding RNAs. Annu Rev Immunol. 2017 Apr 26;35(1):177–198.
   PubMed Web of Science ®Google Scholar
• Chen YG, Satpathy AT, Chang HY. Gene regulation in the immune system by long noncoding RNAs. Nat Immunol. 2017 Aug 22;18(9):962–972.
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.
   PubMed Web of Science ®Google Scholar
• Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000 Jun;56(2):337–344.
   PubMed Web of Science ®Google Scholar
• Aran D. Cell-type enrichment analysis of bulk transcriptomes using xCell. Methods Mol Biol. 2020;2120:263–276.
   PubMedGoogle Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017 Nov 1;77(21):e108–e110.
   PubMed Web of Science ®Google Scholar
• Plattner C, Finotello F, Rieder D. Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quanTIseq. Methods Enzymol. 2020;636:261–285.
   PubMed Web of Science ®Google Scholar
• Becht E, Giraldo NA, Lacroix L, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016 Oct 20;17(1):218. Erratum in: Genome Biol. 2016 Dec 1;17 (1):249.
   PubMed Web of Science ®Google Scholar
• Racle J, Gfeller D. EPIC: a tool to estimate the proportions of different cell types from bulk gene expression data. Methods Mol Biol. 2020;2120:233–248.
   PubMedGoogle Scholar
• Sturm G, Finotello F, Petitprez F, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019 Jul 15;35(14):i436–i445. PMID: 31510660; PMCID: PMC6612828.
   PubMed Web of Science ®Google Scholar
• Chen B, Khodadoust MS, Liu CL, et al. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
   PubMedGoogle Scholar
• Adelstein D, Gillison ML, Pfister DG, et al. NCCN guidelines insights: head and neck cancers, version 2.2017. J Natl Compr Canc Netw. 2017 Jun;15(6):761–770.
   PubMed Web of Science ®Google Scholar
• Jiang H, Ma B, Xu W, et al. A Novel Three-lncRNA Signature Predicts the Overall Survival of HNSCC Patients. Ann Surg Oncol. 2021 Jun;28(6):3396–3406.
   PubMed Web of Science ®Google Scholar
• Liu G, Zheng J, Zhuang L, et al. A prognostic 5-lncRNA expression signature for head and neck squamous cell carcinoma. Sci Rep. 2018 Oct 15;8(1):15250.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017 Jul 3;45(W1):W98–W102.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang S, Ren Y, et al. The role of lncRNA crosstalk in leading cancer metastasis of head and neck squamous cell carcinoma. Front Oncol. 2020 Oct 2;10:561833.
   PubMed Web of Science ®Google Scholar
• Peng L, Chen Y, Ou Q, et al. LncRNA MIAT correlates with immune infiltrates and drug reactions in hepatocellular carcinoma. Int Immunopharmacol. 2020 Dec;89(Pt A):107071.
   PubMed Web of Science ®Google Scholar
• Gu Y, Wan C, Zhou G, et al. TYMSOS drives the proliferation, migration and invasion of gastric cancer cells by regulating ZNF703 via sponging miR-4739. Cell Biol Int. 2021 Apr 13.
   Web of Science ®Google Scholar
• Zhou C, An N, Cao C, et al. lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β-catenin signaling. J Gene Med. 2020 Sep;22(9):e3202.
   PubMed Web of Science ®Google Scholar
• Dong Y, Li X, Lin Z, et al. HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer. J Exp Clin Cancer Res. 2019 Dec 23;38(1):502.
   PubMed Web of Science ®Google Scholar
• Cai WY, Chen X, Chen LP, et al. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis. J Cell Biochem. 2018 Nov;119(10):8249–8259.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang Z, Zhang G, et al. A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy. Clin Transl Med. 2020 Aug;10(4):e156.
   PubMed Web of Science ®Google Scholar
• Qing L, Gu P, Liu M, et al. Six-lncRNA signature as a novel prognostic biomarker for bladder cancer. Onco Targets Ther. 2020 Dec 7;13:12521–12538.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Cao W, Wu K, et al. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. J Exp Clin Cancer Res. 2019 Aug 20;38(1):365.
   PubMed Web of Science ®Google Scholar
• Lu T, Liu H, You G. Long non-coding RNA C5orf66-AS1 prevents oral squamous cell carcinoma through inhibiting cell growth and metastasis. Int J Mol Med. 2018 Dec;42(6):3291–3299.
   PubMed Web of Science ®Google Scholar
• Lee TW, Lai A, Harms JK, et al. Patient-derived xenograft and organoid models for precision medicine targeting of the tumour microenvironment in head and neck cancer. Cancers (Basel). 2020 Dec 12;12(12):3743.
   PubMed Web of Science ®Google Scholar
• Xing B, Qiao XF, Qiu YH, et al. TMPO-AS1 regulates the aggressiveness-associated traits of nasopharyngeal carcinoma cells through sponging miR-320a. Cancer Manag Res. 2021 Jan 15;13:415–425.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen H, Mao B, et al. Transcriptional Characterization of the tumor immune microenvironment and its prognostic value for locally advanced lung adenocarcinoma in a Chinese population. Cancer Manag Res. 2019 Oct 31;11:9165–9173.
   PubMed Web of Science ®Google Scholar
• Ge PL, Li SF, Wang WW, et al. Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma. Aging (Albany NY). 2020 Mar 25;12(6):5479–5499.
   PubMedGoogle Scholar